SGC-CBP30: Selective CREBBP/EP300 Bromodomain Inhibitor f...
2026-03-31
SGC-CBP30 is the go-to CREBBP/EP300 bromodomain inhibitor for dissecting transcriptional and epigenetic mechanisms in cancer biology. Its proven selectivity and robust performance streamline studies of super-enhancer hijacking, TGF-β/SMAD3 signaling, and histone acetylation modulation—empowering researchers to decode transcriptional dysregulation with high confidence.
Salinomycin (SKU A3785): Reliable Solutions for Cancer Ce...
2026-03-30
This article uses scenario-driven Q&A to address common challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Salinomycin (SKU A3785) offers reproducible, literature-backed solutions. Researchers will find guidance on mechanism, protocol optimization, data interpretation, and vendor selection, all grounded in peer-reviewed data and best practices for hepatocellular carcinoma research.
Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Reliable ...
2026-03-30
This in-depth guide addresses persistent laboratory challenges in protein phosphorylation preservation using Phosphatase Inhibitor Cocktail (2 Tubes, 100X) (SKU K1015). Through scenario-driven Q&A, we demonstrate best practices, product reliability, and scientific rationale for integrating this reagent into workflows involving immunoblotting, kinase assays, and mass spectrometry. The article delivers actionable insights for researchers seeking reproducible, quantitative outcomes.
Brassinolide: Applied Research Breakthroughs in Plant and...
2026-03-29
Brassinolide, a potent plant growth regulator, fuels innovation at the intersection of plant science and biomedical research. This article provides actionable protocols, troubleshooting insights, and comparative workflow advantages for researchers leveraging Brassinolide (SKU A3265, APExBIO) in plant assays, apoptosis studies, and metabolic disease models.
Scenario-Driven Best Practices for IPA-3 (SKU B2169) in C...
2026-03-28
This in-depth guide addresses real-world laboratory challenges in kinase activity and cell viability assays by leveraging IPA-3 (SKU B2169), a selective non-ATP competitive Pak1 inhibitor. Drawing on scientific literature, practical experience, and product data, we explore how IPA-3 from APExBIO ensures reproducibility, selectivity, and workflow optimization for biomedical researchers.
RG7388: Selective p53-MDM2 Inhibitor for Cancer Cell Apop...
2026-03-27
RG7388 is a potent, selective MDM2 antagonist that activates the p53 pathway, inducing apoptosis in wild-type p53 cancer cells. This article details its biological rationale, molecular mechanism, evidence benchmarks, and parameters for use in preclinical and translational oncology research.
Transforming p53 Pathway Modulation: Strategic Insights a...
2026-03-27
This thought-leadership article explores the mechanistic underpinnings, experimental validation, and translational opportunities of JNJ-26854165 (Serdemetan)—a potent HDM2 ubiquitin ligase antagonist and p53 activator. Integrating systems biology perspectives, it offers strategic guidance for translational researchers seeking to leverage Serdemetan in advanced cancer models, in vitro drug evaluation, and radiosensitization studies. The article contextualizes current evidence, including recent advances in in vitro metrics for drug response, and uniquely positions Serdemetan as a pivotal tool in the evolving landscape of p53 pathway modulation.
5-Methyl-CTP (SKU B7967): Scenario-Driven Solutions for R...
2026-03-26
This evidence-based guide explores how 5-Methyl-CTP (SKU B7967) addresses persistent challenges in mRNA synthesis workflows, from enhancing transcript stability to ensuring reproducible gene expression results. Through five real-world laboratory scenarios, it demonstrates the scientific rationale and practical value of this modified nucleotide for in vitro transcription, supporting researchers in cell viability, proliferation, and cytotoxicity studies.
Jasplakinolide: Precision Actin Polymerization Inducer fo...
2026-03-26
Jasplakinolide is a potent, membrane-permeable actin polymerization inducer and filament stabilizer. Its nanomolar F-actin binding affinity and unique ability to modulate cytoskeletal dynamics make it a benchmark tool for actin research and antifungal studies.
Maraviroc (A8311): Selective CCR5 Antagonist for HIV-1 En...
2026-03-26
Maraviroc is a potent, selective CCR5 antagonist used in HIV-1 entry inhibition and neuroinflammation research. This article details its molecular mechanism, performance benchmarks, and integration into experimental workflows, supporting reproducibility in AIDS and ischemic stroke investigations.
Anlotinib Hydrochloride: Charting the Next Frontier in An...
2026-03-25
Anlotinib hydrochloride (from APExBIO) is redefining the paradigm for anti-angiogenic research through potent, multi-target tyrosine kinase inhibition. This article blends mechanistic insight with actionable, scenario-driven guidance for translational researchers, uniquely integrating recent case-based clinical evidence with best practices for experimental design. Building upon core literature and hands-on workflow articles, we illuminate the evolving landscape of VEGFR2, PDGFRβ, and FGFR1 inhibition—offering a forward-looking perspective on how Anlotinib can empower the next generation of cancer biology and therapeutic discovery.
Ionomycin Calcium Salt: Advanced Insights into Calcium Si...
2026-03-24
Explore the multifaceted role of ionomycin calcium salt in modulating intracellular calcium and driving apoptosis induction in cancer cells. This in-depth analysis uniquely connects calcium ionophore mechanisms with the latest discoveries in calcium signaling and metastasis.
Azithromycin: Macrolide Antibiotic Workflows for Bacteria...
2026-03-24
Azithromycin, a macrolide antibiotic, is an indispensable tool for researchers investigating bacterial protein synthesis inhibition, resistance mechanisms, and trypanosomosis. This guide details robust in vitro and in vivo workflows, advanced applications, and troubleshooting strategies, leveraging APExBIO’s high-purity Azithromycin for reproducible and insightful results.
Crizotinib Hydrochloride: Precision ALK, c-Met, and ROS1 ...
2026-03-23
Crizotinib hydrochloride is a potent ATP-competitive inhibitor targeting ALK, c-Met, and ROS1 kinases, enabling high-fidelity modeling of oncogenic signaling in cancer research. Its well-characterized mechanism and benchmarked in vitro potency make it a preferred tool for dissecting kinase-driven tumorigenesis and drug resistance. This article details the biological rationale, validated use cases, and operational parameters for effective integration in modern cancer biology workflows.
Fingolimod (FTY720): S1P Receptor Modulator for Multiple ...
2026-03-23
Fingolimod (FTY720) is an orally bioavailable S1P receptor modulator approved for multiple sclerosis (MS) therapy. It reduces lymphocyte egress from lymph nodes and upregulates BDNF in the CNS, supporting both immunomodulation and neuroprotection. This article details its mechanism, benchmarks, and application parameters.
466 records 24/32 page Previous Next First page 上5页 2122232425 下5页 Last page